13F Pro Quality Score
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Reported revenue, net income and operating margin by fiscal year, from Nyxoah SA's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $10.0M | $-90.1M | — |
| FY 2024 | 20-F | $4.5M | $-59.2M | — |
| FY 2023 | 20-F | $4.3M | $-43.2M | — |
| FY 2022 | 20-F | $3.1M | $-31.2M | — |
| FY 2021 | 20-F | $852.0K | $-27.6M | — |
| FY 2020 | 20-F | $69.0K | $-12.2M | — |
Nyxoah SA (NYXH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NYXH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Nyxoah SA reports quarterly revenue of $10.0M, net income of $-90.1M, free cash flow of $-69.8M. Top institutional holders of NYXH by reported 13-F value include AIGH Capital Management, BNP Paribas Asset Management Holding S.A., Axxion S.A., based on the most recent SEC filings. NYXH trades on the Nasdaq exchange and files with the SEC under CIK 1857190. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NYXH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nyxoah SA directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1857190 →